Aprogen Biologics Amends CB Issuance Dates
에이프로젠바이오로직스
003060
Signal Score
Historical Avg Return (5d)
+0.61%
Data Coverage
100%n=2286
Risk-adjusted indicator based on 2286 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Bond Maturity Date: 2029-06-23 (amended from 2029-06-04)
- • Subscription Date: 2026-06-22 (amended from 2026-06-02)
- • Payment Date: 2026-06-23 (amended from 2026-06-04)
- • Put Option First Exercise Date: 2027-12-23 (amended from 2027-12-04)
- • Principal Repayment at Maturity: 106.3412% of face value
AI Analysis Summary
Aprogen Biologics Inc. filed an amendment to its Material Fact Report regarding the issuance of convertible bonds. The amendment primarily adjusts various key dates related to the bond, including the bond maturity date, interest payment dates, principal repayment date, conversion request period, and put option exercise dates. The subscription date is now 2026-06-22, and the payment date is 2026-06-23. The principal repayment at maturity remains at 106.3412% of the face value. These changes are administrative and do not alter the fundamental terms or financial impact of the convertible bond issuance itself, thus having a neutral financial impact.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.